Pre-clinical Positioning
AGADA performs efficacy testing in mouse models of human disease.
Efficacy testing in mouse models is a key ‘de-risking’ step in drug development, particularly for rare genetic diseases (orphan drug development).
AGADA aids in the development, design, and execution of robust efficacy studies including:
Efficacy testing in mouse models is a key ‘de-risking’ step in drug development, particularly for rare genetic diseases (orphan drug development).
AGADA aids in the development, design, and execution of robust efficacy studies including:
- Functional outcomes
- Biomarker outcomes
- Histology
- Dissection and sample processing
Studies are done under strict QA/QC environment including extensive training of staff on protocols and procedures.
Pre-clinical efficacy studies are increasingly required by regulators to show a ‘proof of concept’ for granting of orphan drug status. AGADA has provided many of these regulatory-ready studies.
With hundreds of efficacy studies in many mouse models of neuromuscular disease, AGADA brings a wealth of experience to carryout your efficacy studies in mouse models
Pre-clinical efficacy studies are increasingly required by regulators to show a ‘proof of concept’ for granting of orphan drug status. AGADA has provided many of these regulatory-ready studies.
With hundreds of efficacy studies in many mouse models of neuromuscular disease, AGADA brings a wealth of experience to carryout your efficacy studies in mouse models
